Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 057110/0752 | |
| Pages: | 7 |
| | Recorded: | 08/06/2021 | | |
| Attorney Dkt #: | ASX-001PC/114293-5001 |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY AND RECEIVING PARTY DATA PREVIOUSLY RECORDED AT REEL: 052405 FRAME: 0563. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15776971
|
Filing Dt:
|
05/17/2018
|
|
Publication #:
|
|
Pub Dt:
|
11/29/2018
| | |
PCT #:
|
US2016062816
|
|
Title:
|
PEPTIDES WITH ANTI-ANGIOGENIC, ANTI-LYMPHANGIOGENIC, AND ANTI-EDEMIC PROPERTIES AND NANOPARTICLE FORMULATIONS
|
|
|
Assignee
|
|
|
|
|
| 3400 NORTH CHARLES STREET |
| BALTIMORE, MARYLAND 21218 |
|
|
Correspondence name and address
|
| |
MARK L. HAYMAN
|
| |
MORGAN, LEWIS & BOCKIUS LLP
|
| |
1111 PENNSYLVANIA AVE, N.W.
|
| |
WASHINGTON, DC 20004
|
Search Results as of:
06/23/2024 10:36 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
